Nitrate Vasodilator [EPC]

Nitrate Vasodilator [EPC] was reported 88734 times

Drugs of the Nitrate Vasodilator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIOSPASM 416 0.7455
1 IMMUNISATION 261 0.6014
2 PALMOPLANTAR KERATODERMA 402 0.5545
3 VAGINAL FLATULENCE 163 0.5380
4 AMAUROSIS FUGAX 249 0.2312
5 ATRIAL TACHYCARDIA 437 0.2079
6 SEDATION COMPLICATION 485 0.1899
7 MULTIPLE DRUG THERAPY 142 0.1883
8 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 169 0.1823
9 PRURITUS GENITAL 417 0.1769
10 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 159 0.1497
11 NEPHROGENIC ANAEMIA 610 0.1316
12 HYPERPARATHYROIDISM SECONDARY 327 0.1304
13 CREATININE RENAL CLEARANCE DECREASED 516 0.1288
14 CAROTID ARTERY OCCLUSION 470 0.1287
15 FEMALE GENITAL TRACT FISTULA 174 0.1018
16 TENSION HEADACHE 428 0.0994
17 SLEEP TERROR 408 0.0968
18 PRINZMETAL ANGINA 90 0.0905
19 ANGINA UNSTABLE 577 0.0887
20 CREATININE RENAL CLEARANCE INCREASED 66 0.0882
21 LEFT ATRIAL DILATATION 107 0.0839
22 TOTAL LUNG CAPACITY DECREASED 133 0.0832
23 ISCHAEMIC CARDIOMYOPATHY 255 0.0831
24 RADICULOPATHY 217 0.0823
25 OESOPHAGEAL SPASM 143 0.0775
26 REBOUND ACID HYPERSECRETION 225 0.0743
27 ESSENTIAL HYPERTENSION 126 0.0688
28 PROCTITIS 183 0.0653
29 ANGINA PECTORIS 1795 0.0626
30 SICK SINUS SYNDROME 71 0.0617
31 CHRONIC SINUSITIS 231 0.0615
32 RALES 355 0.0611
33 CORONARY ARTERY DISEASE 1831 0.0604
34 CORONARY ARTERIAL STENT INSERTION 292 0.0575
35 END STAGE RENAL DISEASE 1030 0.0564
36 ORTHOPNOEA 177 0.0555
37 ARTERIOSPASM CORONARY 222 0.0553
38 LUNG OPACITY 141 0.0534
39 CORONARY ARTERY STENOSIS 269 0.0534
40 PLEURITIC PAIN 147 0.0532
41 SUBARACHNOID HAEMORRHAGE 542 0.0532
42 ARTERIOSCLEROSIS CORONARY ARTERY 349 0.0526
43 URINARY TRACT DISORDER 233 0.0517
44 VENTRICULAR TACHYCARDIA 852 0.0515
45 ANGIOPLASTY 76 0.0509
46 ORTHOSTATIC HYPOTENSION 887 0.0509
47 BLOOD CALCIUM DECREASED 571 0.0507
48 CARDIOACTIVE DRUG LEVEL INCREASED 66 0.0502
49 FACIAL PAIN 440 0.0492
50 ACUTE MYOCARDIAL INFARCTION 1436 0.0486
51 ATRIOVENTRICULAR BLOCK FIRST DEGREE 210 0.0484
52 OBSTRUCTIVE SLEEP APNOEA SYNDROME 70 0.0480
53 MYOCARDIAL ISCHAEMIA 539 0.0473
54 CORONARY ARTERY OCCLUSION 642 0.0468
55 PERIPHERAL VASCULAR DISORDER 240 0.0465
56 VENTRICULAR DYSFUNCTION 119 0.0458
57 HAEMORRHAGIC STROKE 357 0.0457
58 HAEMORRHAGIC ANAEMIA 197 0.0448
59 INTERMITTENT CLAUDICATION 68 0.0429
60 COLONIC POLYP 69 0.0417
61 CAROTID ARTERY STENOSIS 145 0.0415
62 LEFT VENTRICULAR HYPERTROPHY 176 0.0411
63 HYPERLIPIDAEMIA 491 0.0410
64 THERAPEUTIC AGENT TOXICITY 136 0.0407
65 MITRAL VALVE INCOMPETENCE 458 0.0404
66 DIASTOLIC DYSFUNCTION 124 0.0401
67 RENAL FAILURE CHRONIC 304 0.0395
68 VENTRICULAR HYPERTROPHY 99 0.0394
69 VASCULITIS 458 0.0393
70 LEFT VENTRICULAR FAILURE 135 0.0392
71 BUNDLE BRANCH BLOCK LEFT 165 0.0389
72 RENAL INJURY 1148 0.0386
73 AORTIC STENOSIS 132 0.0379
74 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 123 0.0371
75 DILATATION VENTRICULAR 78 0.0371
76 HYPERPHOSPHATAEMIA 79 0.0367
77 TROPONIN INCREASED 278 0.0365
78 TRICUSPID VALVE INCOMPETENCE 285 0.0358
79 ACUTE CORONARY SYNDROME 296 0.0357
80 CORONARY ARTERY THROMBOSIS 72 0.0357
81 CARDIOMEGALY 437 0.0355
82 HYPERTENSIVE HEART DISEASE 66 0.0353
83 CARDIAC FAILURE CONGESTIVE 2791 0.0347
84 CHRONIC KIDNEY DISEASE 2576 0.0339
85 NON-CARDIAC CHEST PAIN 107 0.0338
86 MULTI-ORGAN FAILURE 584 0.0337
87 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 74 0.0337
88 GASTRIC POLYPS 75 0.0332
89 SUPRAVENTRICULAR EXTRASYSTOLES 112 0.0331
90 AORTIC ARTERIOSCLEROSIS 84 0.0326
91 MULTIPLE INJURIES 205 0.0325
92 OESOPHAGEAL PAIN 125 0.0316
93 BRONCHIECTASIS 213 0.0316
94 ARTERIOSCLEROSIS 289 0.0307
95 DIABETIC NEUROPATHY 152 0.0307
96 VENTRICULAR HYPOKINESIA 98 0.0305
97 BENIGN PROSTATIC HYPERPLASIA 157 0.0304
98 CATHETERISATION CARDIAC 134 0.0302
99 ECONOMIC PROBLEM 457 0.0301
100 SPUTUM DISCOLOURED 286 0.0301
101 HYPOVOLAEMIA 176 0.0300
102 TRANSIENT ISCHAEMIC ATTACK 1014 0.0300
103 ANOSMIA 428 0.0295
104 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 73 0.0295
105 ARTERIAL OCCLUSIVE DISEASE 232 0.0295
106 CARDIAC FAILURE CHRONIC 125 0.0293
107 AORTIC VALVE INCOMPETENCE 124 0.0291
108 STENT PLACEMENT 234 0.0290
109 MACULAR DEGENERATION 346 0.0289
110 VENTRICULAR EXTRASYSTOLES 300 0.0289
111 DIPLOPIA 748 0.0288
112 CARDIAC MURMUR 249 0.0287
113 FEAR 774 0.0287
114 ANHEDONIA 756 0.0287
115 BLOOD LOSS ANAEMIA 65 0.0287
116 MYOCARDIAL INFARCTION 4993 0.0286
117 PERICARDITIS 480 0.0285
118 LOWER GASTROINTESTINAL HAEMORRHAGE 210 0.0284
119 CORONARY ARTERY BYPASS 163 0.0283
120 BRAIN NATRIURETIC PEPTIDE INCREASED 87 0.0282
121 LYMPHOEDEMA 195 0.0282
122 NEPHROGENIC SYSTEMIC FIBROSIS 85 0.0281
123 BREATH SOUNDS ABNORMAL 137 0.0278
124 GENERALISED OEDEMA 341 0.0275
125 VENTRICULAR FIBRILLATION 301 0.0271
126 RENAL FAILURE 3588 0.0270
127 DIVERTICULUM 192 0.0270
128 DYSLIPIDAEMIA 137 0.0269
129 PRODUCT SOLUBILITY ABNORMAL 135 0.0267
130 PEPTIC ULCER 88 0.0265
131 BLOOD PHOSPHORUS INCREASED 72 0.0263
132 LEFT VENTRICULAR DYSFUNCTION 176 0.0262
133 COGNITIVE DISORDER 1212 0.0259
134 SINUS BRADYCARDIA 250 0.0258
135 RENAL FUNCTION TEST ABNORMAL 120 0.0258
136 CARDIAC FAILURE ACUTE 172 0.0258
137 RENAL FAILURE ACUTE 1092 0.0257
138 ATRIAL FLUTTER 205 0.0257
139 HYPERCHOLESTEROLAEMIA 246 0.0255
140 PRESYNCOPE 616 0.0253
141 OCULAR DISCOMFORT 284 0.0253
142 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 128 0.0253
143 OBSTRUCTIVE AIRWAYS DISORDER 281 0.0252
144 CHEST PAIN 4675 0.0252
145 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 103 0.0252
146 UPPER GASTROINTESTINAL HAEMORRHAGE 420 0.0249
147 BLOOD CHLORIDE DECREASED 64 0.0248
148 BLOOD CALCIUM INCREASED 217 0.0247
149 ASPIRATION 270 0.0246
150 ISCHAEMIA 113 0.0246
151 ATELECTASIS 237 0.0245
152 CREPITATIONS 73 0.0245
153 CARDIAC VALVE DISEASE 139 0.0243
154 SLEEP APNOEA SYNDROME 461 0.0241
155 BLOOD UREA INCREASED 404 0.0241
156 ATRIOVENTRICULAR BLOCK SECOND DEGREE 73 0.0240
157 AREFLEXIA 64 0.0240
158 ANXIETY DISORDER 80 0.0239
159 ATRIOVENTRICULAR BLOCK 184 0.0238
160 SEDATION 622 0.0237
161 HIATUS HERNIA 307 0.0237
162 VASCULAR GRAFT 67 0.0232
163 INTERNATIONAL NORMALISED RATIO DECREASED 94 0.0232
164 RENAL CYST 184 0.0231
165 DIVERTICULUM INTESTINAL 101 0.0231
166 HYPERKALAEMIA 790 0.0225
167 MUSCLE TWITCHING 518 0.0224
168 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1172 0.0224
169 BUNDLE BRANCH BLOCK RIGHT 103 0.0224
170 METABOLIC ENCEPHALOPATHY 67 0.0223
171 BRADYCARDIA 1183 0.0223
172 HIGH DENSITY LIPOPROTEIN DECREASED 74 0.0222
173 DUODENITIS 68 0.0221
174 ATRIOVENTRICULAR BLOCK COMPLETE 148 0.0221
175 NORMOCHROMIC NORMOCYTIC ANAEMIA 66 0.0219
176 ACUTE PULMONARY OEDEMA 123 0.0219
177 CARDIOMYOPATHY 323 0.0218
178 IRON DEFICIENCY ANAEMIA 201 0.0218
179 BLOOD CREATINE INCREASED 96 0.0217
180 HAEMATEMESIS 543 0.0214
181 PROTHROMBIN TIME PROLONGED 128 0.0214
182 SPINAL OSTEOARTHRITIS 187 0.0213
183 CEREBRAL ATROPHY 84 0.0211
184 HAEMOPTYSIS 586 0.0210
185 HYPOMAGNESAEMIA 290 0.0208
186 CEREBROVASCULAR DISORDER 62 0.0206
187 CARDIOGENIC SHOCK 295 0.0205
188 CHEST X-RAY ABNORMAL 63 0.0205
189 TINNITUS 941 0.0205
190 BLINDNESS 834 0.0204
191 ECCHYMOSIS 140 0.0204
192 INTERNATIONAL NORMALISED RATIO INCREASED 578 0.0203
193 BLOOD POTASSIUM INCREASED 326 0.0201
194 GASTROINTESTINAL HAEMORRHAGE 1678 0.0201
195 DEPRESSED LEVEL OF CONSCIOUSNESS 793 0.0200
196 PULSELESS ELECTRICAL ACTIVITY 83 0.0198
197 ELECTROCARDIOGRAM ABNORMAL 154 0.0196
198 ATRIAL FIBRILLATION 1895 0.0194
199 CONGESTIVE CARDIOMYOPATHY 81 0.0194
200 VENTRICULAR ARRHYTHMIA 71 0.0194
201 PERIPHERAL ISCHAEMIA 79 0.0193
202 GASTRITIS EROSIVE 90 0.0193
203 PARAESTHESIA ORAL 278 0.0193
204 INJURY 1353 0.0192
205 PULSE ABSENT 91 0.0191
206 GOUT 343 0.0191
207 DYSPNOEA EXERTIONAL 720 0.0191
208 ACUTE KIDNEY INJURY 2925 0.0191
209 ORAL CANDIDIASIS 251 0.0190
210 AZOTAEMIA 76 0.0190
211 PULMONARY OEDEMA 851 0.0190
212 HAEMATURIA 648 0.0189
213 SPINAL COLUMN STENOSIS 89 0.0188
214 HEAD DISCOMFORT 331 0.0187
215 RENAL TUBULAR NECROSIS 182 0.0185
216 HEPARIN-INDUCED THROMBOCYTOPENIA 91 0.0185
217 HYPOTENSION 3694 0.0184
218 DIABETIC RETINOPATHY 62 0.0182
219 RECTAL HAEMORRHAGE 777 0.0181
220 LIP SWELLING 598 0.0179
221 RHABDOMYOLYSIS 741 0.0178
222 CARDIAC FAILURE 1426 0.0177
223 FLANK PAIN 166 0.0177
224 EMPHYSEMA 177 0.0175
225 VAGINAL DISCHARGE 177 0.0175
226 NEPHROPATHY 163 0.0174
227 PULMONARY MASS 260 0.0174
228 DIABETES MELLITUS INADEQUATE CONTROL 309 0.0174
229 CARDIAC PACEMAKER INSERTION 104 0.0174
230 DUODENAL ULCER 123 0.0174
231 EJECTION FRACTION DECREASED 268 0.0172
232 MELAENA 379 0.0172
233 AORTIC ANEURYSM 129 0.0169
234 PAIN OF SKIN 456 0.0169
235 BLOOD PRESSURE SYSTOLIC DECREASED 77 0.0169
236 RENAL IMPAIRMENT 1413 0.0168
237 HYPERVOLAEMIA 83 0.0168
238 DERMATITIS EXFOLIATIVE 84 0.0168
239 TOXIC EPIDERMAL NECROLYSIS 254 0.0167
240 URINE OUTPUT DECREASED 146 0.0167
241 ORGAN FAILURE 67 0.0166
242 DIZZINESS POSTURAL 161 0.0166
243 SYNCOPE 1659 0.0166
244 HALLUCINATION 1218 0.0161
245 IRON DEFICIENCY 72 0.0160
246 BLOOD PRESSURE DIASTOLIC DECREASED 118 0.0160
247 INTESTINAL ISCHAEMIA 88 0.0160
248 FULL BLOOD COUNT ABNORMAL 169 0.0160
249 APPETITE DISORDER 105 0.0158
250 BLOOD MAGNESIUM DECREASED 136 0.0157
251 BLOOD TEST ABNORMAL 221 0.0157
252 HEART RATE IRREGULAR 353 0.0156
253 LUNG INFILTRATION 137 0.0155
254 BLOOD CREATININE INCREASED 1010 0.0155
255 TUBULOINTERSTITIAL NEPHRITIS 289 0.0154
256 COLITIS ISCHAEMIC 104 0.0154
257 PULMONARY HYPERTENSION 321 0.0154
258 CARDIO-RESPIRATORY ARREST 642 0.0153
259 ALTERED STATE OF CONSCIOUSNESS 331 0.0153
260 RHINITIS ALLERGIC 68 0.0153
261 SUPRAVENTRICULAR TACHYCARDIA 146 0.0152
262 FLUID OVERLOAD 220 0.0151
263 HYPERURICAEMIA 62 0.0151
264 PLEURAL EFFUSION 917 0.0151
265 HEART RATE DECREASED 529 0.0150
266 ASCITES 442 0.0150
267 RASH PAPULAR 337 0.0150
268 BLOOD PRESSURE SYSTOLIC INCREASED 293 0.0150
269 BALANCE DISORDER 1296 0.0150
270 PHOTOPHOBIA 282 0.0150
271 MYASTHENIA GRAVIS 121 0.0150
272 HAEMORRHOIDS 292 0.0150
273 HAEMORRHOIDAL HAEMORRHAGE 73 0.0149
274 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 132 0.0149
275 HYPOXIA 524 0.0149
276 HYPERKERATOSIS 82 0.0148
277 PULMONARY FIBROSIS 285 0.0148
278 CARDIAC DISORDER 1390 0.0148
279 MYOSITIS 133 0.0148
280 OEDEMA PERIPHERAL 1803 0.0148
281 HAEMODIALYSIS 124 0.0148
282 ANGIOEDEMA 651 0.0147
283 OBESITY 234 0.0147
284 HYPOGLYCAEMIA 712 0.0147
285 ACUTE RESPIRATORY FAILURE 281 0.0146
286 MYOPATHY 126 0.0146
287 HYPONATRAEMIA 821 0.0146
288 POST PROCEDURAL HAEMORRHAGE 168 0.0144
289 UNEVALUABLE EVENT 1090 0.0144
290 BLOOD URIC ACID INCREASED 83 0.0144
291 POLYP 94 0.0143
292 DRUG INTERACTION 2272 0.0143
293 SUSPECTED SUICIDE 67 0.0143
294 EYE PRURITUS 480 0.0143
295 PARKINSONISM 139 0.0142
296 GASTROOESOPHAGEAL REFLUX DISEASE 1145 0.0142
297 BLOOD ALBUMIN DECREASED 112 0.0141
298 GASTRIC ULCER HAEMORRHAGE 78 0.0141
299 MICTURITION URGENCY 160 0.0140
300 COAGULOPATHY 233 0.0140
301 RESPIRATION ABNORMAL 96 0.0139
302 EXTRASYSTOLES 97 0.0139
303 HAEMATOMA 360 0.0139
304 PULMONARY CONGESTION 183 0.0139
305 CIRCULATORY COLLAPSE 236 0.0138
306 OLIGURIA 86 0.0138
307 HYPOPHOSPHATAEMIA 102 0.0138
308 WHEEZING 817 0.0138
309 GASTRITIS 362 0.0137
310 ANGIOPATHY 77 0.0137
311 AMNESIA 892 0.0137
312 BLOOD PRESSURE DECREASED 911 0.0137
313 TACHYCARDIA 1204 0.0135
314 GLOMERULAR FILTRATION RATE DECREASED 166 0.0135
315 IMPAIRED GASTRIC EMPTYING 184 0.0135
316 OSTEOARTHRITIS 569 0.0134
317 ABDOMINAL HERNIA 61 0.0134
318 BODY HEIGHT DECREASED 143 0.0134
319 HYPOVOLAEMIC SHOCK 64 0.0133
320 DEHYDRATION 1780 0.0133
321 HYPERTENSIVE CRISIS 147 0.0132
322 HAEMATOCRIT DECREASED 261 0.0131
323 CHEST DISCOMFORT 1346 0.0131
324 GASTRIC ULCER 249 0.0131
325 FLUID RETENTION 666 0.0131
326 MENTAL STATUS CHANGES 363 0.0131
327 BLADDER DISORDER 129 0.0130
328 BLOOD PRESSURE INADEQUATELY CONTROLLED 78 0.0130
329 MOBILITY DECREASED 931 0.0129
330 LEUKOCYTOSIS 234 0.0129
331 FALL 4285 0.0129
332 INTERVERTEBRAL DISC DEGENERATION 119 0.0128
333 PRODUCTIVE COUGH 609 0.0127
334 TORSADE DE POINTES 100 0.0127
335 CLOSTRIDIUM DIFFICILE COLITIS 135 0.0127
336 EXOSTOSIS 116 0.0127
337 INTERNAL HAEMORRHAGE 145 0.0127
338 CARDIAC ARREST 1046 0.0127
339 ISCHAEMIC STROKE 226 0.0127
340 BLOOD CREATINE PHOSPHOKINASE INCREASED 364 0.0126
341 HYPOKALAEMIA 582 0.0126
342 TYPE 2 DIABETES MELLITUS 424 0.0126
343 ULCER HAEMORRHAGE 85 0.0125
344 DEMENTIA 351 0.0125
345 ANAEMIA 2393 0.0125
346 OESOPHAGITIS 137 0.0125
347 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 64 0.0125
348 VITAMIN D DEFICIENCY 121 0.0124
349 FAECES DISCOLOURED 265 0.0122
350 BRADYKINESIA 72 0.0122
351 DISTURBANCE IN ATTENTION 652 0.0121
352 SUBDURAL HAEMATOMA 173 0.0121
353 CEREBRAL ISCHAEMIA 62 0.0120
354 ANOREXIA 155 0.0120
355 ARRHYTHMIA 568 0.0120
356 BLOOD SODIUM DECREASED 226 0.0120
357 PALPITATIONS 1402 0.0120
358 POLYURIA 98 0.0120
359 NOCTURIA 145 0.0119
360 REFUSAL OF TREATMENT BY PATIENT 78 0.0119
361 CYSTITIS 380 0.0119
362 DYSPNOEA 6754 0.0119
363 ULCER 188 0.0118
364 FIBROMYALGIA 287 0.0118
365 HEMIPLEGIA 98 0.0118
366 CHOLECYSTITIS 140 0.0117
367 INCREASED TENDENCY TO BRUISE 108 0.0117
368 HYPERHIDROSIS 1512 0.0117
369 LOWER RESPIRATORY TRACT INFECTION 533 0.0117
370 MALNUTRITION 131 0.0117
371 HYPOCALCAEMIA 220 0.0116
372 ELECTROLYTE IMBALANCE 135 0.0116
373 CONSTIPATION 2532 0.0116
374 UROSEPSIS 107 0.0116
375 DIABETES MELLITUS 881 0.0115
376 UPPER RESPIRATORY TRACT INFECTION 534 0.0115
377 CELLULITIS 582 0.0115
378 DELIRIUM 400 0.0115
379 BLOOD TRIGLYCERIDES INCREASED 203 0.0115
380 HEART RATE INCREASED 1136 0.0115
381 HOSPICE CARE 113 0.0114
382 MUSCULAR WEAKNESS 1294 0.0114
383 EPISTAXIS 847 0.0113
384 BRONCHITIS 836 0.0113
385 TYPE 1 DIABETES MELLITUS 68 0.0113
386 DIALYSIS 160 0.0113
387 RESPIRATORY RATE INCREASED 100 0.0113
388 SKIN ULCER 291 0.0112
389 RIB FRACTURE 231 0.0112
390 BLOOD PRESSURE FLUCTUATION 269 0.0112
391 GANGRENE 67 0.0111
392 MUSCULOSKELETAL CHEST PAIN 172 0.0111
393 HYPERTHYROIDISM 160 0.0110
394 DECUBITUS ULCER 90 0.0110
395 OSTEOPOROSIS 454 0.0110
396 POST PROCEDURAL COMPLICATION 211 0.0110
397 CONTUSION 1055 0.0109
398 SHOCK 252 0.0109
399 DYSURIA 402 0.0109
400 ANURIA 93 0.0108
401 HEPATIC STEATOSIS 201 0.0108
402 HAEMOGLOBIN DECREASED 1108 0.0108
403 FREQUENT BOWEL MOVEMENTS 291 0.0108
404 HAEMATOCHEZIA 594 0.0108
405 GROIN PAIN 94 0.0107
406 CHOLELITHIASIS 351 0.0107
407 LARGE INTESTINE POLYP 74 0.0107
408 BODY TEMPERATURE DECREASED 105 0.0107
409 GLUCOSE TOLERANCE IMPAIRED 63 0.0106
410 TENDERNESS 111 0.0106
411 HYPERGLYCAEMIA 388 0.0106
412 BLOOD PRESSURE ABNORMAL 211 0.0106
413 CARDIOVASCULAR DISORDER 269 0.0106
414 LOCALISED INFECTION 256 0.0106
415 UNRESPONSIVE TO STIMULI 273 0.0106
416 BLOOD POTASSIUM DECREASED 318 0.0106
417 JOINT INJURY 225 0.0105
418 RESPIRATORY FAILURE 767 0.0105
419 RENAL DISORDER 486 0.0104
420 DIZZINESS 5193 0.0104
421 RESPIRATORY DISTRESS 287 0.0104
422 MIDDLE INSOMNIA 194 0.0104
423 LIVER FUNCTION TEST INCREASED 223 0.0104
424 HYPERTENSION 2199 0.0104
425 EYE PAIN 585 0.0104
426 CARDIAC FLUTTER 67 0.0104
427 CEREBROVASCULAR ACCIDENT 1753 0.0103
428 SEPSIS 1152 0.0103
429 BLOOD PRESSURE INCREASED 1576 0.0103
430 ANXIETY 2915 0.0102
431 CARDIAC OPERATION 88 0.0102
432 SHOCK HAEMORRHAGIC 83 0.0102
433 HALLUCINATION, VISUAL 215 0.0102
434 HEAD INJURY 322 0.0102
435 ABDOMINAL PAIN UPPER 2093 0.0102
436 HEMIPARESIS 172 0.0101
437 MULTIPLE ORGAN DYSFUNCTION SYNDROME 287 0.0101
438 PERICARDIAL EFFUSION 234 0.0101
439 LOW DENSITY LIPOPROTEIN INCREASED 78 0.0101
440 TRANSAMINASES INCREASED 224 0.0101
441 URINARY RETENTION 335 0.0100
442 COMA 478 0.0100
443 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 103 0.0100
444 DYSPEPSIA 985 0.0100
445 RIGHT VENTRICULAR FAILURE 70 0.0100
446 ASTHENIA 3745 0.0099
447 ACIDOSIS 76 0.0099
448 CYANOSIS 156 0.0099
449 COLITIS 375 0.0099
450 LACERATION 93 0.0099
451 COLD SWEAT 174 0.0099
452 CARPAL TUNNEL SYNDROME 138 0.0098
453 HAEMORRHAGE INTRACRANIAL 147 0.0098
454 HYPOTONIA 98 0.0098
455 PALLOR 267 0.0098
456 PROCEDURAL PAIN 272 0.0098
457 PNEUMONIA 3171 0.0098
458 URINARY INCONTINENCE 290 0.0098
459 OEDEMA 530 0.0098
460 BACK PAIN 2268 0.0098
461 BLOOD COUNT ABNORMAL 148 0.0098
462 BLOOD CHOLESTEROL INCREASED 453 0.0097
463 RESTLESS LEGS SYNDROME 176 0.0097
464 LIVER FUNCTION TEST ABNORMAL 281 0.0097
465 INCONTINENCE 102 0.0096
466 TRANSFUSION 101 0.0096
467 FULL BLOOD COUNT DECREASED 194 0.0096
468 INTERVERTEBRAL DISC PROTRUSION 210 0.0096
469 PERIPHERAL SWELLING 1468 0.0095
470 PURPURA 84 0.0095
471 CHROMATURIA 214 0.0095
472 DIVERTICULITIS 262 0.0094
473 MIGRAINE 902 0.0094
474 SPINAL COMPRESSION FRACTURE 78 0.0094
475 COUGH 2636 0.0094
476 URINARY TRACT INFECTION 1594 0.0093
477 SPLENOMEGALY 109 0.0093
478 ACTIVITIES OF DAILY LIVING IMPAIRED 184 0.0093
479 JOINT EFFUSION 64 0.0093
480 BLOOD IRON DECREASED 110 0.0093
481 CONFUSIONAL STATE 1491 0.0092
482 SINUS TACHYCARDIA 131 0.0092
483 OSTEOPENIA 140 0.0092
484 CEREBRAL INFARCTION 225 0.0092
485 NECK PAIN 511 0.0091
486 PROCEDURAL COMPLICATION 70 0.0091
487 LOSS OF CONSCIOUSNESS 1169 0.0091
488 WEIGHT FLUCTUATION 95 0.0091
489 WHITE BLOOD CELL COUNT INCREASED 347 0.0090
490 WOUND INFECTION 99 0.0090
491 SINUS CONGESTION 122 0.0090
492 MEMORY IMPAIRMENT 1239 0.0090
493 ASTHMA 1019 0.0090
494 MOUTH HAEMORRHAGE 66 0.0090
495 OSTEOMYELITIS 163 0.0090
496 APNOEA 70 0.0090
497 BURSITIS 109 0.0090
498 GASTROENTERITIS 131 0.0090
499 OXYGEN SATURATION DECREASED 503 0.0089
500 BLOOD GLUCOSE FLUCTUATION 98 0.0089
501 MULTIPLE ALLERGIES 70 0.0089
502 PETECHIAE 93 0.0089
503 BACTERIAL INFECTION 166 0.0089
504 PERIPHERAL COLDNESS 122 0.0089
505 LIMB INJURY 240 0.0088
506 SEASONAL ALLERGY 125 0.0088
507 NEUTROPENIC SEPSIS 63 0.0088
508 FACIAL PARALYSIS 75 0.0088
509 BLOOD URINE PRESENT 167 0.0088
510 ANKLE FRACTURE 136 0.0088
511 DISORIENTATION 348 0.0088
512 INTENTIONAL PRODUCT MISUSE 767 0.0088
513 BLOOD GLUCOSE INCREASED 1646 0.0087
514 EOSINOPHILIA 153 0.0087
515 MYOCLONUS 104 0.0087
516 ABDOMINAL PAIN 2024 0.0087
517 MYALGIA 1479 0.0087
518 DYSARTHRIA 327 0.0087
519 HYDRONEPHROSIS 65 0.0087
520 JOINT RANGE OF MOTION DECREASED 116 0.0086
521 MUSCULOSKELETAL DISCOMFORT 148 0.0086
522 EMOTIONAL DISTRESS 1037 0.0086
523 MUSCLE STRAIN 74 0.0085
524 RETCHING 182 0.0085
525 DEPRESSION 1941 0.0085
526 METABOLIC ACIDOSIS 271 0.0085
527 GLAUCOMA 163 0.0085
528 MOTOR DYSFUNCTION 86 0.0084
529 NEURALGIA 205 0.0084
530 CEREBRAL HAEMORRHAGE 301 0.0084
531 HYPOTHYROIDISM 268 0.0084
532 SKIN LACERATION 91 0.0084
533 BACTERAEMIA 99 0.0083
534 MUSCULOSKELETAL PAIN 435 0.0083
535 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 141 0.0083
536 MUSCLE ATROPHY 105 0.0083
537 BACK INJURY 90 0.0083
538 ATAXIA 98 0.0082
539 ELECTROCARDIOGRAM QT PROLONGED 297 0.0082
540 ROTATOR CUFF SYNDROME 106 0.0082
541 PAIN 5064 0.0082
542 LETHARGY 473 0.0082
543 STAPHYLOCOCCAL INFECTION 271 0.0082
544 STEVENS-JOHNSON SYNDROME 182 0.0082
545 PULMONARY HAEMORRHAGE 64 0.0082
546 ABASIA 201 0.0081
547 HYPOKINESIA 118 0.0081
548 INITIAL INSOMNIA 83 0.0081
549 BLISTER 453 0.0081
550 HYPOPHAGIA 206 0.0080
551 RED BLOOD CELL COUNT DECREASED 230 0.0080
552 SUDDEN DEATH 85 0.0080
553 INSOMNIA 2132 0.0080
554 CHOKING 156 0.0080
555 HYPERSOMNIA 229 0.0080
556 PROSTATIC SPECIFIC ANTIGEN INCREASED 110 0.0080
557 ASPARTATE AMINOTRANSFERASE INCREASED 424 0.0080
558 VISUAL IMPAIRMENT 988 0.0080
559 WEIGHT DECREASED 2220 0.0079
560 CATARACT 467 0.0078
561 GINGIVAL BLEEDING 107 0.0078
562 DECREASED APPETITE 1820 0.0078
563 ERYTHEMA MULTIFORME 73 0.0078
564 PLATELET COUNT INCREASED 102 0.0078
565 POLLAKIURIA 326 0.0078
566 VISION BLURRED 1072 0.0078
567 HIP FRACTURE 251 0.0078
568 SKIN CANCER 168 0.0078
569 MALAISE 3413 0.0078
570 CHILLS 901 0.0077
571 ABDOMINAL DISCOMFORT 1289 0.0077
572 DYSSTASIA 224 0.0077
573 ANAL INCONTINENCE 69 0.0077
574 RESPIRATORY DISORDER 229 0.0076
575 PNEUMONIA BACTERIAL 70 0.0076
576 RESPIRATORY TRACT CONGESTION 121 0.0076
577 NERVE COMPRESSION 70 0.0076
578 GASTRIC HAEMORRHAGE 87 0.0076
579 KIDNEY INFECTION 148 0.0075
580 SCIATICA 120 0.0075
581 DECREASED ACTIVITY 81 0.0075
582 SWOLLEN TONGUE 234 0.0075
583 BONE DISORDER 136 0.0075
584 VOMITING 3506 0.0074
585 BLOOD ALKALINE PHOSPHATASE INCREASED 185 0.0074
586 BLOOD LACTATE DEHYDROGENASE INCREASED 118 0.0074
587 SPINAL FRACTURE 149 0.0074
588 TACHYPNOEA 101 0.0074
589 TREMOR 1232 0.0074
590 BLOOD GLUCOSE DECREASED 356 0.0074
591 DIARRHOEA 4768 0.0074
592 PAIN IN EXTREMITY 2173 0.0074
593 RESPIRATORY TRACT INFECTION 192 0.0074
594 DRUG LEVEL INCREASED 122 0.0074
595 DYSPHAGIA 699 0.0074
596 PSEUDOMONAS INFECTION 63 0.0073
597 HEPATIC CIRRHOSIS 138 0.0073
598 GALLBLADDER DISORDER 131 0.0073
599 PAIN IN JAW 207 0.0073
600 LUNG DISORDER 356 0.0073
601 WRIST FRACTURE 87 0.0073
602 LABORATORY TEST ABNORMAL 214 0.0072
603 PYREXIA 2508 0.0072
604 FATIGUE 5637 0.0072
605 PHARMACEUTICAL PRODUCT COMPLAINT 188 0.0072
606 SINUS DISORDER 143 0.0072
607 PNEUMONIA ASPIRATION 180 0.0072
608 PSYCHOLOGICAL TRAUMA 62 0.0072
609 MEDICATION ERROR 399 0.0072
610 DISSEMINATED INTRAVASCULAR COAGULATION 101 0.0072
611 RENAL PAIN 76 0.0072
612 PANCREATITIS ACUTE 161 0.0072
613 PYELONEPHRITIS 62 0.0071
614 FEELING ABNORMAL 1711 0.0071
615 UPPER LIMB FRACTURE 142 0.0071
616 HEPATOMEGALY 70 0.0071
617 AGITATION 522 0.0071
618 TENDONITIS 110 0.0071
619 THROMBOSIS 571 0.0071
620 MUSCLE SPASMS 1301 0.0071
621 INTENTIONAL PRODUCT USE ISSUE 621 0.0071
622 RESPIRATORY ARREST 195 0.0071
623 BACK DISORDER 115 0.0071
624 PHARYNGEAL OEDEMA 108 0.0070
625 SKIN DISCOLOURATION 322 0.0070
626 HAEMORRHAGE 725 0.0069
627 SMALL INTESTINAL OBSTRUCTION 85 0.0069
628 HERNIA 133 0.0069
629 FOOT FRACTURE 130 0.0069
630 ARTHRITIS 539 0.0068
631 HEADACHE 4290 0.0068
632 NEUTROPHIL COUNT INCREASED 70 0.0068
633 HEPATIC FAILURE 206 0.0068
634 DRUG TOXICITY 93 0.0068
635 GENERAL PHYSICAL HEALTH DETERIORATION 789 0.0068
636 GAIT DISTURBANCE 1304 0.0068
637 COORDINATION ABNORMAL 95 0.0068
638 NAUSEA 5377 0.0068
639 FEELING COLD 189 0.0068
640 SCAR 116 0.0068
641 DYSPHONIA 396 0.0068
642 TOXICITY TO VARIOUS AGENTS 1141 0.0068
643 ARTHRALGIA 2802 0.0067
644 GLYCOSYLATED HAEMOGLOBIN INCREASED 170 0.0067
645 EYE INFECTION 76 0.0067
646 WOUND 188 0.0067
647 MUSCULOSKELETAL STIFFNESS 587 0.0067
648 DRY THROAT 68 0.0067
649 ADRENAL INSUFFICIENCY 81 0.0067
650 ERUCTATION 129 0.0067
651 RHINORRHOEA 429 0.0066
652 ABDOMINAL DISTENSION 691 0.0066
653 PANCREATITIS 349 0.0066
654 ENCEPHALOPATHY 162 0.0066
655 EAR PAIN 128 0.0066
656 SOMNOLENCE 1323 0.0066
657 DRY MOUTH 532 0.0066
658 BASAL CELL CARCINOMA 102 0.0065
659 ILEUS 81 0.0065
660 FLATULENCE 369 0.0065
661 TREATMENT NONCOMPLIANCE 356 0.0065
662 FOOT DEFORMITY 72 0.0065
663 HYPOAESTHESIA 968 0.0065
664 DEAFNESS 169 0.0065
665 PULMONARY EMBOLISM 613 0.0064
666 LIVER DISORDER 285 0.0064
667 LACTIC ACIDOSIS 208 0.0064
668 PLATELET COUNT DECREASED 683 0.0064
669 SPINAL PAIN 75 0.0064
670 VERTIGO 390 0.0064
671 SEPTIC SHOCK 278 0.0064
672 BLINDNESS UNILATERAL 90 0.0064
673 INFUSION RELATED REACTION 422 0.0064
674 HYPOACUSIS 274 0.0064
675 DEEP VEIN THROMBOSIS 413 0.0063
676 HYPERCALCAEMIA 78 0.0063
677 SWELLING 591 0.0063
678 ORAL PAIN 141 0.0063
679 PRURITUS GENERALISED 136 0.0063
680 MUSCLE RIGIDITY 75 0.0063
681 LIGAMENT SPRAIN 62 0.0063
682 LIMB DISCOMFORT 194 0.0063
683 STOMATITIS 380 0.0063
684 NEPHROLITHIASIS 287 0.0063
685 CONJUNCTIVITIS 116 0.0062
686 SPEECH DISORDER 327 0.0062
687 BURNING SENSATION 437 0.0062
688 THROMBOCYTOPENIA 694 0.0062
689 NERVE INJURY 69 0.0062
690 NEUROPATHY PERIPHERAL 589 0.0062
691 BREAST PAIN 66 0.0062
692 PNEUMOTHORAX 98 0.0062
693 PRURITUS 2374 0.0062
694 SLUGGISHNESS 63 0.0062
695 ALANINE AMINOTRANSFERASE INCREASED 379 0.0062
696 BEDRIDDEN 81 0.0062
697 MASS 86 0.0061
698 BLOOD GLUCOSE ABNORMAL 113 0.0061
699 IRRITABLE BOWEL SYNDROME 131 0.0061
700 TOOTH ABSCESS 62 0.0061
701 COVID-19 1067 0.0061
702 RED BLOOD CELL SEDIMENTATION RATE INCREASED 67 0.0060
703 SCAB 69 0.0060
704 MUSCLE TIGHTNESS 98 0.0060
705 RESTLESSNESS 221 0.0060
706 BLOOD BILIRUBIN INCREASED 163 0.0060
707 TEMPERATURE INTOLERANCE 62 0.0060
708 EMOTIONAL DISORDER 185 0.0060
709 SLEEP DISORDER 422 0.0060
710 GAMMA-GLUTAMYLTRANSFERASE INCREASED 132 0.0060
711 SEROTONIN SYNDROME 114 0.0059
712 CLOSTRIDIUM DIFFICILE INFECTION 129 0.0059
713 SKIN LESION 162 0.0059
714 COLITIS ULCERATIVE 263 0.0059
715 PRODUCT QUALITY ISSUE 799 0.0059
716 SCRATCH 62 0.0059
717 EATING DISORDER 125 0.0059
718 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 417 0.0059
719 DEPRESSED MOOD 309 0.0058
720 THYROID DISORDER 90 0.0058
721 COLON CANCER 87 0.0058
722 VISUAL ACUITY REDUCED 193 0.0058
723 CANDIDA INFECTION 98 0.0058
724 SENSORY DISTURBANCE 93 0.0058
725 DYSKINESIA 235 0.0058
726 LYMPHOCYTE COUNT DECREASED 102 0.0058
727 SYNOVITIS 104 0.0058
728 TOOTH INFECTION 76 0.0058
729 PANCYTOPENIA 322 0.0058
730 NERVOUSNESS 301 0.0058
731 COVID-19 PNEUMONIA 68 0.0058
732 SKIN HAEMORRHAGE 85 0.0057
733 LUNG INFECTION 89 0.0057
734 GASTROINTESTINAL PAIN 63 0.0057
735 DRY SKIN 763 0.0057
736 TOOTH FRACTURE 63 0.0057
737 DISABILITY 113 0.0057
738 NIGHT SWEATS 184 0.0057
739 BODY TEMPERATURE INCREASED 116 0.0057
740 MYELODYSPLASTIC SYNDROME 82 0.0057
741 HALLUCINATION, AUDITORY 90 0.0057
742 APHASIA 171 0.0057
743 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 97 0.0057
744 IMPAIRED QUALITY OF LIFE 81 0.0056
745 SINUSITIS 576 0.0056
746 NASAL CONGESTION 330 0.0056
747 OROPHARYNGEAL PAIN 519 0.0056
748 MOVEMENT DISORDER 180 0.0056
749 THIRST 100 0.0056
750 TENDON RUPTURE 69 0.0056
751 HOT FLUSH 421 0.0056
752 POOR QUALITY SLEEP 120 0.0056
753 INTESTINAL OBSTRUCTION 210 0.0056
754 FLUSHING 566 0.0056
755 ACUTE HEPATIC FAILURE 76 0.0056
756 INTERSTITIAL LUNG DISEASE 269 0.0055
757 FEELING HOT 340 0.0055
758 FEEDING DISORDER 112 0.0055
759 INFLUENZA 613 0.0055
760 NO THERAPEUTIC RESPONSE 67 0.0055
761 SKIN DISORDER 182 0.0055
762 ROAD TRAFFIC ACCIDENT 228 0.0054
763 GASTROINTESTINAL DISORDER 488 0.0054
764 LOCAL SWELLING 95 0.0054
765 QUALITY OF LIFE DECREASED 73 0.0054
766 NODULE 71 0.0054
767 PHARYNGITIS 67 0.0054
768 GASTROENTERITIS VIRAL 97 0.0054
769 ACUTE RESPIRATORY DISTRESS SYNDROME 95 0.0054
770 JOINT SWELLING 648 0.0054
771 CONVULSION 307 0.0054
772 THROAT TIGHTNESS 145 0.0054
773 WEIGHT INCREASED 1200 0.0054
774 BRONCHOSPASM 76 0.0053
775 TASTE DISORDER 108 0.0053
776 EYE HAEMORRHAGE 71 0.0053
777 PRODUCT TASTE ABNORMAL 72 0.0053
778 MOUTH ULCERATION 112 0.0053
779 CONDITION AGGRAVATED 1615 0.0053
780 SNEEZING 119 0.0053
781 GASTRIC DISORDER 182 0.0053
782 LOWER LIMB FRACTURE 101 0.0053
783 MUSCULOSKELETAL DISORDER 100 0.0052
784 JAUNDICE 141 0.0052
785 IMPAIRED HEALING 172 0.0052
786 PNEUMONITIS 142 0.0052
787 DELUSION 81 0.0052
788 RASH ERYTHEMATOUS 249 0.0052
789 HEPATITIS 132 0.0052
790 PROTEINURIA 98 0.0051
791 HERPES ZOSTER 294 0.0051
792 SECRETION DISCHARGE 64 0.0051
793 ABNORMAL DREAMS 141 0.0051
794 ERECTILE DYSFUNCTION 131 0.0051
795 PARALYSIS 73 0.0051
796 LUNG NEOPLASM MALIGNANT 209 0.0051
797 ARTHROPATHY 281 0.0051
798 TOOTHACHE 91 0.0050
799 C-REACTIVE PROTEIN INCREASED 182 0.0050
800 PRODUCT PRESCRIBING ERROR 119 0.0050
801 COMPLETED SUICIDE 416 0.0050
802 HAIR COLOUR CHANGES 62 0.0050
803 RASH MACULAR 173 0.0049
804 THERAPY NON-RESPONDER 222 0.0049
805 PARAESTHESIA 773 0.0049
806 RASH PRURITIC 266 0.0049
807 TOOTH DISORDER 109 0.0049
808 BONE PAIN 287 0.0049
809 DRUG PRESCRIBING ERROR 94 0.0049
810 GAIT INABILITY 163 0.0049
811 EYE DISORDER 160 0.0049
812 HAIR TEXTURE ABNORMAL 65 0.0049
813 ILL-DEFINED DISORDER 295 0.0049
814 ALOPECIA 952 0.0048
815 ERYTHEMA 996 0.0048
816 SWELLING FACE 315 0.0048
817 THROAT IRRITATION 217 0.0048
818 DEVICE OCCLUSION 68 0.0048
819 LYMPHADENOPATHY 171 0.0048
820 PRODUCT ADMINISTRATION ERROR 97 0.0048
821 CHOLESTASIS 92 0.0048
822 MENTAL DISORDER 207 0.0048
823 DIABETIC KETOACIDOSIS 114 0.0047
824 JOINT STIFFNESS 124 0.0047
825 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 227 0.0047
826 LACRIMATION INCREASED 141 0.0047
827 APHONIA 65 0.0047
828 PERITONITIS 96 0.0046
829 RASH 1998 0.0046
830 PANIC ATTACK 167 0.0046
831 PRESCRIBED UNDERDOSE 91 0.0046
832 NASOPHARYNGITIS 835 0.0045
833 RASH GENERALISED 117 0.0045
834 DYSGEUSIA 335 0.0045
835 ANAPHYLACTIC REACTION 249 0.0045
836 FUNGAL INFECTION 149 0.0045
837 WHITE BLOOD CELL COUNT DECREASED 484 0.0045
838 ORAL DISCOMFORT 62 0.0045
839 INTENTIONAL DOSE OMISSION 127 0.0045
840 AGEUSIA 111 0.0044
841 LIVER INJURY 109 0.0044
842 DRUG INTOLERANCE 428 0.0044
843 IMMUNODEFICIENCY 66 0.0044
844 THINKING ABNORMAL 82 0.0044
845 DRUG ADMINISTRATION ERROR 135 0.0044
846 HEPATIC FUNCTION ABNORMAL 164 0.0044
847 FACE OEDEMA 74 0.0044
848 GLOSSODYNIA 98 0.0044
849 EYE SWELLING 162 0.0044
850 ABDOMINAL PAIN LOWER 110 0.0043
851 FEMUR FRACTURE 134 0.0043
852 INFECTION 626 0.0043
853 INSURANCE ISSUE 66 0.0043
854 DEATH 3698 0.0043
855 PLASMA CELL MYELOMA 166 0.0043
856 ADVERSE DRUG REACTION 382 0.0042
857 FEELING JITTERY 81 0.0042
858 DRUG-INDUCED LIVER INJURY 133 0.0042
859 VIRAL INFECTION 141 0.0042
860 NERVOUS SYSTEM DISORDER 132 0.0042
861 DEVICE RELATED INFECTION 65 0.0042
862 KNEE ARTHROPLASTY 88 0.0042
863 PHOTOSENSITIVITY REACTION 69 0.0042
864 PARANOIA 72 0.0042
865 SURGERY 244 0.0042
866 CONTRAINDICATED PRODUCT ADMINISTERED 126 0.0042
867 PRODUCT DOSE OMISSION 270 0.0041
868 INFLAMMATION 213 0.0041
869 EAR INFECTION 109 0.0041
870 OFF LABEL USE 3535 0.0040
871 INTENTIONAL DRUG MISUSE 84 0.0040
872 INCORRECT PRODUCT ADMINISTRATION DURATION 87 0.0040
873 HOSPITALISATION 616 0.0040
874 ABSCESS 63 0.0039
875 TARDIVE DYSKINESIA 111 0.0039
876 HEPATIC ENZYME INCREASED 268 0.0039
877 INCREASED APPETITE 75 0.0039
878 OSTEONECROSIS OF JAW 97 0.0039
879 TOOTH LOSS 81 0.0039
880 AGRANULOCYTOSIS 72 0.0039
881 AGGRESSION 193 0.0039
882 THERAPEUTIC RESPONSE UNEXPECTED 173 0.0039
883 DISEASE RECURRENCE 183 0.0038
884 DRY EYE 192 0.0038
885 FEBRILE NEUTROPENIA 255 0.0038
886 ANAPHYLACTIC SHOCK 99 0.0038
887 WRONG TECHNIQUE IN DRUG USAGE PROCESS 139 0.0038
888 RASH MACULO-PAPULAR 85 0.0038
889 THERAPY CESSATION 194 0.0038
890 FRACTURE 71 0.0037
891 EXTRAPYRAMIDAL DISORDER 93 0.0037
892 URTICARIA 618 0.0037
893 SEIZURE 426 0.0037
894 DISCOMFORT 224 0.0037
895 HYPERSENSITIVITY 678 0.0036
896 ILLNESS 376 0.0036
897 ABNORMAL BEHAVIOUR 144 0.0036
898 CRYING 132 0.0036
899 PRESCRIBED OVERDOSE 70 0.0036
900 NIGHTMARE 125 0.0036
901 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 196 0.0036
902 IMPAIRED WORK ABILITY 76 0.0036
903 DISEASE PROGRESSION 419 0.0035
904 PRODUCT DOSE OMISSION ISSUE 1034 0.0035
905 PRODUCT USE IN UNAPPROVED INDICATION 859 0.0035
906 SKIN EXFOLIATION 291 0.0034
907 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 245 0.0034
908 DERMATITIS 72 0.0034
909 INFLUENZA LIKE ILLNESS 282 0.0034
910 MENTAL IMPAIRMENT 82 0.0034
911 INCORRECT DRUG ADMINISTRATION DURATION 93 0.0033
912 DRUG INEFFECTIVE 4316 0.0033
913 INTENTIONAL OVERDOSE 209 0.0033
914 EYE IRRITATION 187 0.0032
915 DRUG DOSE OMISSION 536 0.0032
916 THERAPY INTERRUPTED 231 0.0032
917 PRODUCT USE ISSUE 606 0.0032
918 SUICIDAL IDEATION 294 0.0032
919 PSORIATIC ARTHROPATHY 130 0.0032
920 PRODUCT DOSE OMISSION IN ERROR 90 0.0032
921 BONE MARROW FAILURE 64 0.0031
922 PRODUCT PHYSICAL ISSUE 63 0.0031
923 ADVERSE EVENT 286 0.0031
924 RHEUMATOID ARTHRITIS 352 0.0031
925 OCULAR HYPERAEMIA 145 0.0031
926 DEVICE MALFUNCTION 212 0.0030
927 NEUTROPHIL COUNT DECREASED 122 0.0030
928 LEUKOPENIA 149 0.0030
929 DRUG RESISTANCE 76 0.0030
930 ANGER 99 0.0029
931 ACCIDENTAL OVERDOSE 107 0.0029
932 SUICIDE ATTEMPT 177 0.0029
933 NEOPLASM MALIGNANT 194 0.0029
934 BONE DENSITY DECREASED 91 0.0029
935 IRRITABILITY 173 0.0029
936 DEVICE DISLOCATION 124 0.0028
937 SYSTEMIC LUPUS ERYTHEMATOSUS 101 0.0028
938 PSYCHOTIC DISORDER 84 0.0028
939 MOOD ALTERED 77 0.0028
940 OVERDOSE 608 0.0028
941 EPILEPSY 86 0.0028
942 NEUTROPENIA 380 0.0028
943 ECZEMA 146 0.0028
944 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 499 0.0028
945 THERAPEUTIC PRODUCT EFFECT DECREASED 124 0.0028
946 PSORIASIS 359 0.0027
947 DRUG EFFECT DECREASED 148 0.0027
948 UNDERDOSE 200 0.0027
949 PRODUCT AVAILABILITY ISSUE 62 0.0027
950 PRODUCT SUBSTITUTION ISSUE 154 0.0027
951 OSTEONECROSIS 85 0.0026
952 INCORRECT DOSE ADMINISTERED 582 0.0025
953 EXPIRED PRODUCT ADMINISTERED 83 0.0025
954 MOOD SWINGS 79 0.0025
955 THERAPEUTIC RESPONSE DECREASED 150 0.0025
956 MALIGNANT NEOPLASM PROGRESSION 243 0.0024
957 INJECTION SITE BRUISING 188 0.0024
958 PANCREATIC CARCINOMA 68 0.0024
959 DRUG EFFECT INCOMPLETE 85 0.0023
960 GYNAECOMASTIA 70 0.0023
961 WITHDRAWAL SYNDROME 95 0.0023
962 PREMATURE BABY 68 0.0023
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 422 0.0021
964 DRUG ABUSE 173 0.0021
965 NEOPLASM PROGRESSION 72 0.0021
966 INJECTION SITE MASS 72 0.0019
967 PROSTATE CANCER 139 0.0017
968 INJECTION SITE HAEMORRHAGE 135 0.0017
969 EXTRA DOSE ADMINISTERED 68 0.0017
970 VAGINAL HAEMORRHAGE 70 0.0016
971 MULTIPLE SCLEROSIS 76 0.0016
972 SKIN BURNING SENSATION 111 0.0015
973 MULTIPLE SCLEROSIS RELAPSE 106 0.0015
974 SKIN IRRITATION 70 0.0015
975 INJECTION SITE PAIN 464 0.0015
976 EXPOSURE DURING PREGNANCY 94 0.0015
977 INJECTION SITE SWELLING 112 0.0015
978 DEVICE ISSUE 128 0.0014
979 DRUG WITHDRAWAL SYNDROME 119 0.0014
980 INJECTION SITE PRURITUS 89 0.0013
981 DERMATITIS ATOPIC 69 0.0013
982 DEVICE DIFFICULT TO USE 86 0.0013
983 INJECTION SITE ERYTHEMA 157 0.0013
984 NO ADVERSE EVENT 208 0.0011
985 BREAST CANCER 106 0.0011
986 INJECTION SITE REACTION 76 0.0011
987 BLADDER CANCER 65 0.0011
988 TREATMENT FAILURE 91 0.0011
989 PRODUCT STORAGE ERROR 95 0.0011
990 DRUG DEPENDENCE 167 0.0010
991 ACCIDENTAL EXPOSURE TO PRODUCT 106 0.0010
992 FOETAL EXPOSURE DURING PREGNANCY 81 0.0010
993 ACNE 72 0.0009
994 MATERNAL EXPOSURE DURING PREGNANCY 79 0.0009